Ezzeldin M. Ibrahim

2.7k total citations · 1 hit paper
75 papers, 2.1k citations indexed

About

Ezzeldin M. Ibrahim is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ezzeldin M. Ibrahim has authored 75 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ezzeldin M. Ibrahim's work include Lung Cancer Treatments and Mutations (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Breast Cancer Treatment Studies (11 papers). Ezzeldin M. Ibrahim is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Breast Cancer Treatment Studies (11 papers). Ezzeldin M. Ibrahim collaborates with scholars based in Saudi Arabia, Japan and United Kingdom. Ezzeldin M. Ibrahim's co-authors include Mubarak Al‐Μansour, Ghieth A. Kazkaz, Fatma A. Al-Mulhim, Adnan Ezzat, Meteb Al‐Foheidi, Ahmed A. Zeeneldin, Robert K. Stuart, Dahish Ajarim, Jamal Zekri and M.A. Raja and has published in prestigious journals such as Spine, Journal of neurosurgery and British Journal of Cancer.

In The Last Decade

Ezzeldin M. Ibrahim

72 papers receiving 2.0k citations

Hit Papers

Physical activity and sur... 2010 2026 2015 2020 2010 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies
    2010 431 citations Ezzeldin M. Ibrahim et al. Medical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ezzeldin M. Ibrahim Saudi Arabia 25 1.3k 373 366 335 271 75 2.1k
Katherine Van Loon United States 21 956 0.7× 213 0.6× 293 0.8× 267 0.8× 256 0.9× 126 1.7k
Laura Giordano Italy 31 982 0.8× 519 1.4× 230 0.6× 873 2.6× 318 1.2× 165 3.3k
Yacine Merrouche France 27 1.7k 1.3× 450 1.2× 271 0.7× 578 1.7× 161 0.6× 103 2.5k
Howard M. Gross United States 27 1.4k 1.1× 446 1.2× 530 1.4× 538 1.6× 143 0.5× 55 2.6k
Louis A. Leone United States 26 1.2k 0.9× 368 1.0× 339 0.9× 582 1.7× 372 1.4× 59 2.4k
Mohamad Bassam Sonbol United States 27 1.1k 0.9× 262 0.7× 295 0.8× 560 1.7× 475 1.8× 133 2.5k
Reda Wilson United States 20 985 0.8× 153 0.4× 375 1.0× 460 1.4× 431 1.6× 42 2.3k
Shital Kamble United States 16 1.4k 1.1× 620 1.7× 297 0.8× 380 1.1× 125 0.5× 36 2.4k
Alexandra Easson Canada 22 730 0.6× 189 0.5× 207 0.6× 262 0.8× 355 1.3× 65 1.8k
Robin Zoň United States 25 931 0.7× 136 0.4× 375 1.0× 517 1.5× 161 0.6× 71 2.1k

Countries citing papers authored by Ezzeldin M. Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Ezzeldin M. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezzeldin M. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezzeldin M. Ibrahim more than expected).

Fields of papers citing papers by Ezzeldin M. Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezzeldin M. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezzeldin M. Ibrahim. The network helps show where Ezzeldin M. Ibrahim may publish in the future.

Co-authorship network of co-authors of Ezzeldin M. Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Ezzeldin M. Ibrahim. A scholar is included among the top collaborators of Ezzeldin M. Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezzeldin M. Ibrahim. Ezzeldin M. Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ibrahim, Ezzeldin M., et al.. (2020). Energy and caloric restriction, and fasting and cancer: a narrative review. Supportive Care in Cancer. 29(5). 2299–2304. 28 indexed citations
3.
Al‐Μansour, Mubarak, et al.. (2017). Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia. Oncology Research and Treatment. 40(5). 288–292. 13 indexed citations
4.
5.
Al‐Μansour, Mubarak, et al.. (2015). Bleomycin Pulmonary Toxicity in Adult Saudi Patients with Hodgkin’s Lymphoma. Future Oncology. 11(15). 2149–2157. 4 indexed citations
6.
Ibrahim, Ezzeldin M., et al.. (2012). Increased Risk of Second Lung Cancer in Hodgkin’s Lymphoma Survivors: A Meta-analysis. Lung. 191(1). 117–134. 27 indexed citations
7.
Ibrahim, Ezzeldin M., et al.. (2012). Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis. BMC Cancer. 12(1). 197–197. 49 indexed citations
8.
Ibrahim, Ezzeldin M., et al.. (2011). Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials. Medical Oncology. 28(S1). 310–317. 15 indexed citations
9.
Ibrahim, Ezzeldin M., et al.. (2010). Prognostic value of lymph node ratio in poor prognosis node‐positive breast cancer patients in Saudi Arabia. Asia-Pacific Journal of Clinical Oncology. 6(2). 130–137. 12 indexed citations
10.
Boulos, Dina N. K., et al.. (2010). An eight-year snapshot of geospatial cancer research (2002–2009): clinico-epidemiological and methodological findings and trends. Medical Oncology. 28(4). 1145–1162. 16 indexed citations
11.
Ibrahim, Ezzeldin M., et al.. (2008). Current and future cancer burden in Saudi Arabia. Hematology/Oncology and Stem Cell Therapy. 1(4). 210–215. 23 indexed citations
12.
Ibrahim, Ezzeldin M., Ahmed A. Zeeneldin, Bakr Bin Sadiq, & Adnan Ezzat. (2008). The present and the future of breast cancer burden in the Kingdom of Saudi Arabia. Medical Oncology. 25(4). 387–393. 77 indexed citations
13.
Ibrahim, Ezzeldin M., et al.. (2005). Adjuvant Chemotherapy in 780 Patients with Early Breast Cancer: 10-Year Data from Saudi Arabia. Medical Oncology. 22(4). 343–352. 11 indexed citations
14.
15.
16.
Ibrahim, Ezzeldin M., Fatma A. Al-Mulhim, Ali Al Bshabshe, et al.. (1998). Breast cancer in the eastern province of Saudi Arabia. Medical Oncology. 15(4). 241–247. 39 indexed citations
17.
18.
Ibrahim, Ezzeldin M., et al.. (1992). Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. British Journal of Radiology. 65(777). 774–778. 125 indexed citations
19.
Ibrahim, Ezzeldin M., et al.. (1991). Public Knowledge, Misperceptions, and Attitudes About Cancer in Saudi Arabia. Annals of Saudi Medicine. 11(5). 518–523. 11 indexed citations
20.
Ibrahim, Ezzeldin M., et al.. (1988). Non-hodgkin's lymphoma in Saudi Arabia: Prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced disease. European Journal of Cancer and Clinical Oncology. 24(3). 391–401. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Van Loon Breakdown of academic impact, for papers by Laura Giordano Breakdown of academic impact, for papers by Yacine Merrouche Breakdown of academic impact, for papers by Howard M. Gross Breakdown of academic impact, for papers by Louis A. Leone Breakdown of academic impact, for papers by Mohamad Bassam Sonbol Breakdown of academic impact, for papers by Reda Wilson Breakdown of academic impact, for papers by Shital Kamble Breakdown of academic impact, for papers by Alexandra Easson Breakdown of academic impact, for papers by Robin Zoň
Rankless by CCL
2026